Macrolide antibacterial
Azithromycin
Binds the 50S ribosomal subunit and blocks bacterial protein synthesis in susceptible organisms.
Primary Mechanism of Action
Clinical / Scientific
Azithromycin binds 23S rRNA in the 50S subunit, inhibiting translocation during translation. High tissue and intracellular concentrations contribute to its pharmacokinetic profile. Immunomodulatory effects on neutrophil and epithelial signalling have been described separately from bactericidal action.
Pathway Targets
50S ribosome
Scientific explanation
Inhibition of bacterial peptide translocation.
Inflammatory signalling
Scientific explanation
Described host immunomodulatory effects distinct from antibacterial binding.
Pathway Convergence
Clinical / Scientific
Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.
Translation arrest
Target to downstream effect: 50S binding → Blocked translocation → Inhibited protein synthesis in susceptible bacteria
Mechanistically Relevant Repurposed & Adjunctive Applications
Susceptible bacterial infections
EstablishedMechanistic rationale
Established macrolide for labelled susceptible infections; resistance is common in some pathogens.
Airway immunomodulation
InvestigationalMechanistic rationale
Long-term low-dose macrolide immunomodulation is studied and used in selected airway diseases under specialist protocols — not a general product claim.
Mechanistic Application Matrix
| Biological Target | Mechanism | Potential Relevance | Evidence Level |
|---|---|---|---|
| 50S ribosome | Translation inhibition | Bacterial protein synthesis | Established mechanism |
| Host inflammatory signalling | Immunomodulation | Airway neutrophil biology | Investigational |
Mechanistic Interaction Considerations
QT-interval prolongation and CYP3A/P-gp interactions are labelled macrolide considerations. Avoid assuming unlisted combinations are safe.
In Plain Language
Azithromycin jams the bacterial protein-making machinery (the ribosome) so susceptible bacteria cannot build the proteins they need.
Compounds Sharing Pathways
Other library compounds whose structured pathway data overlap this ingredient. Shared pathways are not combination recommendations.
Inflammatory signalling
Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.